Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Goodwill (2018 - 2025)

Historic Goodwill for OptimizeRx (OPRX) over the last 8 years, with Q3 2025 value amounting to $70.9 million.

  • OptimizeRx's Goodwill fell 4.37% to $70.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.9 million, marking a year-over-year decrease of 4.37%. This contributed to the annual value of $70.9 million for FY2024, which is 955.63% down from last year.
  • According to the latest figures from Q3 2025, OptimizeRx's Goodwill is $70.9 million, which was down 4.37% from $70.9 million recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Goodwill ranged from a high of $78.4 million in Q4 2023 and a low of $14.7 million during Q1 2021
  • Its 5-year average for Goodwill is $42.1 million, with a median of $22.7 million in 2022.
  • Examining YoY changes over the last 5 years, OptimizeRx's Goodwill showed a top increase of 24558.36% in 2024 and a maximum decrease of 955.63% in 2024.
  • Quarter analysis of 5 years shows OptimizeRx's Goodwill stood at $14.7 million in 2021, then skyrocketed by 53.83% to $22.7 million in 2022, then soared by 245.58% to $78.4 million in 2023, then decreased by 9.56% to $70.9 million in 2024, then changed by 0.0% to $70.9 million in 2025.
  • Its Goodwill stands at $70.9 million for Q3 2025, versus $70.9 million for Q2 2025 and $70.9 million for Q1 2025.